Biology Reference
In-Depth Information
Park, S. S., Schulz, E. M., and Lee, D. (2007). Disruption of dopamine homeostasis underlies selective
neurodegeneration mediated by alpha-synuclein. Eur. J. Neurosci. 26, 3104-3112.
Park, J., Lee, G., and Chung, J. (2009). The PINK1-Parkin pathway is involved in the regulation of
mitochondrial remodeling process. Biochem. Biophys. Res. Commun. 378, 518-523.
Paterna, J. C., Leng, A., Weber, E., Feldon, J., and Bueler, H. (2007). DJ-1 and Parkin modulate
dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice.
Mol. Ther. 15, 698-704.
Pendleton, R. G., Rasheed, A., Sardina, T., Tully, T., and Hillman, R. (2002). Effects of tyrosine
hydroxylase mutants on locomotor activity in Drosophila: A study in functional genomics. Behav.
Genet. 32, 89-94.
Pesah, Y., Pham, T., Burgess, H., Middlebrooks, B., Verstreken, P., Zhou, Y., Harding, M., Bellen, H.,
and Mardon, G. (2004). Drosophila parkin mutants have decreased mass and cell size and
increased sensitivity to oxygen radical stress.
Development 131, 2183-2194.
Pesah, Y., Burgess, H., Middlebrooks, B., Ronningen, K., Prosser, J., Tirunagaru, V., Zysk, J., and
Mardon, G. (2005). Whole-mount analysis reveals normal numbers of dopaminergic neurons
following misexpression of alpha-synuclein in Drosophila.
Genesis 41, 154-159.
Plun-Favreau, H., Klupsch, K., Moisoi, N., Gandhi, S., Kjaer, S., Frith, D., Harvey, K., Deas, E.,
Harvey, R. J., McDonald, N.,
. (2007). The mitochondrial protease HtrA2 is regulated by
Parkinson's disease-associated kinase PINK1.
et al
Nat. Cell Biol. 9, 1243-1252.
Poewe, W. (2009). Treatments for Parkinson disease—Past achievements and current clinical needs.
Neurology 72, S65-S73.
Poole, A. C., Thomas, R. E., Andrews, L. A., McBride, H. M., Whitworth, A. J., and Pallanck, L. J.
(2008). The PINK1/Parkin pathway regulates mitochondrial morphology.
Proc. Natl. Acad. Sci.
USA 105, 1638-1643.
Poole, A. C., Thomas, R. E., Yu, S., Vincow, E. S., and Pallanck, L. (2010). The mitochondrial
fusion-promoting factor mitofusin is a substrate of the PINK1/parkin pathway.
PLoS ONE 5,
e10054.
Quik, M., O'Leary, K., and Tanner, C. M. (2008). Nicotine and Parkinson's disease: Implications for
therapy. Mov. Disord. 23, 1641-1652.
Riparbelli, M. G., and Callaini, G. (2007). The Drosophila parkin homologue is required for normal
mitochondrial dynamics during spermiogenesis. Dev. Biol. 303, 108-120.
Roman, G., Endo, K., Zong, L., and Davis, R. L. (2001). P[Switch], a system for spatial and temporal
control of gene expression in Drosophila melanogaster.
Proc. Natl. Acad. Sci. USA 98,
12602-12607.
Rong, Y. S., and Golic, K. G. (2000). Gene targeting by homologous recombination in Drosophila.
Science 288, 2013-2018.
Rorth, P. (1996). Amodular misexpression screen in Drosophila detecting tissue-specific phenotypes.
Proc. Natl. Acad. Sci. USA 93, 12418-12422.
Rosen, K. M., Veereshwarayya, V., Moussa, C. E., Fu, Q., Goldberg, M. S., Schlossmacher, M. G.,
Shen, J., and Querfurth, H. W. (2006). Parkin protects against mitochondrial toxins and
beta-amyloid accumulation in skeletal muscle cells.
J. Biol. Chem. 281, 12809-12816.
Ross, O. A., Soto, A. I., Vilarino-Guell, C., Heckman, M. G., Diehl, N. N., Hulihan, M. M.,
Aasly, J. O., Sando, S., Gibson, J. M., Lynch, T.,
et al
. (2008). Genetic variation of Omi/HtrA2
Parkinsonism Relat. Disord. 14, 539-543.
Rubin, G. M., Yandell, M. D., Wortman, J. R., Gabor Miklos, G. L., Nelson, C. R., Hariharan, I. K.,
Fortini, M. E., Li, P. W., Apweiler, R., Fleischmann, W.,
and Parkinson's disease.
et al
. (2000). Comparative genomics of
Science 287, 2204-2215.
Ryder, E., and Russell, S. (2003). Transposable elements as tools for genomics and genetics in
Drosophila.
the eukaryotes.
Brief Funct. Genomic. Proteomic. 2, 57-71.